Seller record · Telehealth service

OBU Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The semaglutide page sells compounded semaglutide with no statement that it is not FDA-approved, and the NAD+ page carries none. The tirzepatide and sermorelin pages state that compounded medications are not FDA-approved. 1 more criterion also fails; see the table below.

At a glance

OBU HealthTelehealth service

5/8criteria passed
Price
Semaglutide $190 a month, tirzepatide $239
Sells
compounded semaglutide, compounded tirzepatide, NAD+ injection, and 1 more
FDA letters
None on file
Visit OBU HealthSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A Las Vegas online store selling compounded semaglutide and tirzepatide, NAD+ injections and sermorelin on monthly and multi-month plans, with care from a contracted physician network. Its answers page names Manifest Pharmacy and RX Compounding Store as the filling pharmacies.

Operating entity OBU Health LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSOBU Health's FAQ; OBU Health's website
S2Prescription gatingNOT VERIFIEDOBU Health's GLP-1 semaglutide product page; OBU Health's FAQ
S3Pharmacy identificationPASSOBU Health's FAQ
S4Compounding disclosureFAILOBU Health's GLP-1 semaglutide product page; OBU Health's NAD+ injection product page; OBU Health's tirzepatide product page
S5Analytical documentationFAILOBU Health's NAD+ injection product page; OBU Health's FAQ
S6Business addressPASSOBU Health's contact page; OBU Health's terms of use page; OBU Health's returns and refunds page
S7Price disclosurePASSOBU Health's GLP-1 semaglutide product page; OBU Health's tirzepatide product page; OBU Health's sermorelin product page; OBU Health's NAD+ injection product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSUS-based doctors review each set of medical answers and prescribe only when appropriate, and the answers page names MD Integrations as the provider network.Source: OBU Health's FAQ; OBU Health's website.
S2NOT VERIFIEDThe order path behind the start button on each product page did not resolve, because the button places the plan in a cart that was not opened, while the answers page says the buyer answers medical questions first and is billed when the medication ships. The check is open.Source: OBU Health's GLP-1 semaglutide product page; OBU Health's FAQ.
S3PASSThe answers page names the pharmacies that may fill a prescription: Manifest Pharmacy, 1018 S. Batesville Road, Greer, SC 29650, and RX Compounding Store, 8950 SW 74th Court, Suite 101, Miami, Florida 33156.Source: OBU Health's FAQ.
S4FAILThe semaglutide page sells compounded semaglutide with no statement that it is not FDA-approved, and the NAD+ page carries none. The tirzepatide and sermorelin pages state that compounded medications are not FDA-approved.Source: OBU Health's GLP-1 semaglutide product page; OBU Health's NAD+ injection product page; OBU Health's tirzepatide product page.
S5FAILNo certificate of analysis or lot document is published. The NAD+ page lists a four-test pharmacy quality panel with no document behind the claim.Source: OBU Health's NAD+ injection product page; OBU Health's FAQ.
S6PASSOBU Health LLC at 10845 Griffith Peak Dr., Ste 200, Las Vegas, NV 89135, printed in the footer of every page, on the contact page, in the terms, the privacy policy and the HIPAA notice, and as the returns address. The terms name Georgia law.Source: OBU Health's contact page; OBU Health's terms of use page; OBU Health's returns and refunds page.
S7PASSCompounded semaglutide at $190 a month, $399 for 3 months or $714 for 6 months, and compounded tirzepatide at $239 a month, $589 for 3 months or $1,074 for 6 months, at the same price for every dose. Sermorelin at $149 a month or $379 for 3 months. NAD+ injection at $219 a month, while the comparison table on the same page prints $129 as the starting price.Source: OBU Health's GLP-1 semaglutide product page; OBU Health's tirzepatide product page; OBU Health's sermorelin product page; OBU Health's NAD+ injection product page.
S8PASSNo FDA warning letter names OBU Health or OBU Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+ injection, sermorelin.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit OBU Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.